2000
DOI: 10.1016/s0090-6980(99)00058-1
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of PAF production by incorporation of arachidonic acid and eicosapentaenoic acid in phospholipids of human leukemic monocyte-like cells THP-1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…The endocannabinoids can bind to cannabinoid receptor types 1 and 2, which have anti-inflammatory properties (Artmann et al, 2008;Batetta et al, 2009;Wood et al, 2010). Other studies have shown that through incorporation in the cell membrane, n-3 LC-PUFA reduce the production of platelet-activating factor in certain immune cells (Croft et al, 1986;Pickett et al, 1986;Sperling et al, 1987;Shikano et al, 1993;Martin-Chouly et al, 2000;Watanabe et al, 2001). Finally, incorporation of EPA and DHA disrupts the formation of lipid rafts in the membrane, which can lead to changes in cell signal transduction during inflammation (Reviewed by Pike, 2003).…”
Section: Production Of Lipid Mediators That Resolve Inflammationmentioning
confidence: 99%
“…The endocannabinoids can bind to cannabinoid receptor types 1 and 2, which have anti-inflammatory properties (Artmann et al, 2008;Batetta et al, 2009;Wood et al, 2010). Other studies have shown that through incorporation in the cell membrane, n-3 LC-PUFA reduce the production of platelet-activating factor in certain immune cells (Croft et al, 1986;Pickett et al, 1986;Sperling et al, 1987;Shikano et al, 1993;Martin-Chouly et al, 2000;Watanabe et al, 2001). Finally, incorporation of EPA and DHA disrupts the formation of lipid rafts in the membrane, which can lead to changes in cell signal transduction during inflammation (Reviewed by Pike, 2003).…”
Section: Production Of Lipid Mediators That Resolve Inflammationmentioning
confidence: 99%
“…Feeding cells or animals with n-3 PUFA results in replacement of n-6 with n-3 fatty acid at the sn-2 position [145,236]. n-3 fatty acyl chains (EPA or DHA) in the sn-2 position are poor substrates for cytosolic phospholipase A 2 (cPLA 2 ) [146,147], therefore incorporation of n-3 PUFA may reduce the availability of free AA and consequently n-6 series eicosanoids. In addition, 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine (PC) can be converted to 1-O-alkyl-2-lyso-PC and then to the platelet activating factor (PAF), 1-O-alkyl-2-acetyl-(PC).…”
Section: Mechanism Of Action Of Pufas In Cancer Cellsmentioning
confidence: 99%
“…sPLA2 and cPLA2 can selectively release AA from the sn -2 position of phospholipids and the released AA is then the substrate of oxygenases. Interestingly, phospholipids with ω3 PUFA (EPA or DHA) in the sn -2 position are poor substrates for cPLA2 [84, 85]. In contrast, iPLA2 may selectively release DHA [86].…”
Section: Pufa Oxidation and Cyclingmentioning
confidence: 99%